F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Atherosclerosis

Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880 · see citing works

Lipid peroxidation: its mechanism, measurement, and significance

Halliwell, B. B., & Chirico, S. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.5.715s · Cited by 2,355 · see citing works

Homocysteine and Atherothrombosis

Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997 · see citing works

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,898 · see citing works

Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage

Morrow, J. D., Frei, B. B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,340 · see citing works

The measurement and mechanism of lipid peroxidation in biological systems

Gutteridge, J. M. C., & Halliwell, B. B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,292 · see citing works

Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777 · see citing works

Lewis A. Conner Memorial Lecture

Steinberg, D. H. (1997) · Circulation · doi:10.1161/01.cir.95.4.1062 · Cited by 743 · see citing works

In Vivo Formation of 8-Iso-Prostaglandin F_2αand Platelet Activation in Diabetes Mellitus: Effects of Improved Metabolic Control and Vitamin E Supplementation

Davı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.224 · Cited by 742 · see citing works

Changing concepts of atherogenesis

Libby, P. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00654.x · Cited by 629 · see citing works

Modulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers

Reilly, M., Delanty, N., Lawson, J. A., & FitzGerald, G. A. (1996) · Circulation · doi:10.1161/01.cir.94.1.19 · Cited by 612 · see citing works

Increase of Brain Oxidative Stress in Mild Cognitive Impairment

Praticò, D., Clark, C. M., Liun, F., Lee, V., & Trojanowski, J. Q. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.972 · Cited by 587 · see citing works

Platelet Activation in Obese Women

Davı̀, G., Guagnano, M. T., Ciabattoni, G., Basili, S., Falco, A., Marinopiccoli, M., Nutini, M., Sensi, S., & Patrono, C. (2002) · JAMA · doi:10.1001/jama.288.16.2008 · Cited by 542 · see citing works

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice

Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523 · see citing works

Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.

Kloner, R. A., Przyklenk, K., & Whittaker, P. (1989) · Circulation · doi:10.1161/01.cir.80.5.1115 · Cited by 504 · see citing works

Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice

Praticò, D., Tangirala, R. K., Rader, D. J., Rokach, J., & FitzGerald, G. A. (1998) · Nature Medicine · doi:10.1038/2685 · Cited by 501 · see citing works

Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis

Heinecke, J. W. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00173-7 · Cited by 461 · see citing works

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis

Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 457 · see citing works

Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation

Zhang, R., Brennan, M.-L., Shen, Z., MacPherson, J. C., Schmitt, D., Molenda, C. E., & Hazen, S. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209124200 · Cited by 432 · see citing works

Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice

Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422 · see citing works

Increased F ₂ ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation <i>in vivo</i>

Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405 · see citing works

Plasma 8‐epi‐PGF_2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus

Gopaul, N. K., Änggård, E. E., Mallet, A. I., Betteridge, D. J., Wolff, S. P., & Nourooz-Zadeh, J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00649-t · Cited by 390 · see citing works

In Vivo Formation of 8-Epi-Prostaglandin F2αIs Increased in Hypercholesterolemia

Davı̀, G., Alessandrini, P., Mezzetti, A., Minotti, G., Bucciarelli, T., Costantini, F., Cipollone, F., Bon, G. B., Ciabattoni, G., & Patrono, C. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3230 · Cited by 350 · see citing works

Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

Praticò, D., Iuliano, L., Mauriello, A., Spagnoli, L. G., Lawson, J. A., Rokach, J., Maclouf, J., Violi, F., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119735 · Cited by 344 · see citing works

Repetitive Mild Brain Trauma Accelerates Aβ Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis

Uryu, K., Laurer, H., McIntosh, T., Praticò, D., Martinez, D., Leight, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00446.2002 · Cited by 337 · see citing works

Oxidative Modification of LDL and Atherogenesis

Steinberg, D. H. (1998) · Medical science symposia series · doi:10.1007/978-94-011-5022-4_16 · Cited by 330 · see citing works

Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation.

Morrow, J. D., Awad, J. A., Kato, T., Takahashi, K., Badr, K. F., Roberts, L. J., & Burk, R. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116143 · Cited by 319 · see citing works

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men.

Vaarala, O., Mänttäri, M., Manninen, V., Tenkanen, L., Puurunen, M., Aho, K., & Palosuo, T. (1995) · Circulation · doi:10.1161/01.cir.91.1.23 · Cited by 317 · see citing works

Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase

Tselepis, A. D., & Chapman, M. J. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00045-4 · Cited by 316 · see citing works

Anti-Cardiolipin Antibodies and Risk of Myocardial Infarction in a Prospective Cohort of Middle-Aged Men

OutiVaarala, MattiMänttäri, VesaManninen, LeenaTenkanen, MarjaPuurunen, KimmoAho, & TimoPalosuo (1995) · Circulation · Cited by 305 · see citing works

Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice

Praticò, D., Uryu, K., Sung, S., Tang, S., Trojanowski, J. Q., & Lee, V. M. ‐. (2002) · The FASEB Journal · doi:10.1096/fj.02-0012fje · Cited by 278 · see citing works

Increased Formation of Distinct F2Isoprostanes in Hypercholesterolemia

Reilly, M. P., Praticò, D., Delanty, N., DiMinno, G., Tremoli, E., Rader, D. J., Kapoor, S. C., Rokach, J., Lawson, J. A., & FitzGerald, G. A. (1998) · Circulation · doi:10.1161/01.cir.98.25.2822 · Cited by 271 · see citing works

Effects of Vitamin E on Lipid Peroxidation in Healthy Persons

Meagher, E. A. (2001) · JAMA · doi:10.1001/jama.285.9.1178 · Cited by 269 · see citing works

8-Epi PGF2αGeneration During Coronary Reperfusion

Delanty, N., Reilly, M. P., Praticò, D., Lawson, J. A., McCarthy, J. F., Wood, A., Ohnishi, S. T., Fitzgerald, D. J., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.95.11.2492 · Cited by 267 · see citing works

Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α

Praticò, D., Lawson, J. A., & FitzGerald, G. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9800 · Cited by 266 · see citing works

Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease

Montine, T., Markesbery, W., Morrow, J., & Roberts, L. (1998) · Annals of Neurology · doi:10.1002/ana.410440322 · Cited by 254 · see citing works

Inflammation and therapeutic vaccination in CNS diseases

Weiner, H. L., & Selkoe, D. J. (2002) · Nature · doi:10.1038/nature01325 · Cited by 253 · see citing works

The neurobiologie consequences of down syndrome

Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90074-2 · Cited by 248 · see citing works

Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults

Kluijtmans, L. A. J., Young, I. S., Boreham, C. A., Murray, L., McMaster, D., McNulty, H., Strain, J. J., McPartlin, J. M., Scott, J. M., & Whitehead, A. S. (2003) · Blood · doi:10.1182/blood.v101.7.2483 · Cited by 244 · see citing works

Absence of 12/15-Lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E–Deficient Mice

Cyrus, T., Praticò, D., Zhao, L., Witztum, J. L., Rader, D. J., Rokach, J., FitzGerald, G. A., & Funk, C. D. (2001) · Circulation · doi:10.1161/01.cir.103.18.2277 · Cited by 231 · see citing works

Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable Angina

Cipollone, F., Ciabattoni, G., Patrignani, P., Pasquale, M., Gregorio, D. D., Bucciarelli, T., Davı̀, G., Cuccurullo, F., & Patrono, C. (2000) · Circulation · doi:10.1161/01.cir.102.9.1007 · Cited by 225 · see citing works

[16] Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism

Morrow, J. D., & Roberts, L. J. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)33019-0 · Cited by 225 · see citing works

IPF 2α -I: An index of lipid peroxidation in humans

Praticò, D., Barry, Ó. P., Lawson, J. A., Adiyaman, M., Hwang, S., Khanapure, S. P., Iuliano, L., Rokach, J., & FitzGerald, G. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3449 · Cited by 219 · see citing works

Increased Oxidative Stress and Platelet Activation in Patients With Hypertension and Renovascular Disease

Minuz, P., Patrignani, P., Gaino, S., Degan, M., Menapace, L., Tommasoli, R., Seta, F., Capone, M. L., Tacconelli, S., Palatresi, S., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039528.49161.e9 · Cited by 211 · see citing works

Increased Formation of the Isoprostanes IPF2α-I and 8-Epi-Prostaglandin F2αin Acute Coronary Angioplasty

Reilly, M. P., Delanty, N., Roy, L., Rokach, J., Callaghan, P. O., Crean, P., Lawson, J. A., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.96.10.3314 · Cited by 210 · see citing works

Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels

Voutilainen, S., Morrow, J. D., Roberts, L. J., Alfthan, G., Alho, H., Nyyssönen, K., & Salonen, J. T. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1263 · Cited by 205 · see citing works

Prostaglandin F2-Like Compounds, F2-Isoprostanes, Are Present in Increased Amounts in Human Atherosclerotic Lesions

Gniwotta, C., Morrow, J. D., Roberts, L. J., & Kühn, H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3236 · Cited by 196 · see citing works

Cardiovascular Responses to the Isoprostanes iPF2α-III and iPE2-III Are Mediated via the Thromboxane A2Receptor In Vivo

Audoly, L., Rocca, B., Fabre, J., Koller, B. H., Thomas, D. W., Loeb, A. L., Coffman, T. M., & FitzGerald, G. A. (2000) · Circulation · doi:10.1161/01.cir.101.24.2833 · Cited by 192 · see citing works

The isoprostanes in biology and medicine

Praticò, D. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00411-8 · Cited by 188 · see citing works

The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis

Mallat, Z., Nakamura, T., Ohan, J., Lesèche, G., Tedgui, A., Maclouf, J., & Murphy, R. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3985 · Cited by 172 · see citing works

Oxidized phospholipids and isoprostanes in atherosclerosis

Witztum, J. L., & Berliner, J. A. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00008 · Cited by 170 · see citing works

Homocysteine and atherosclerosis

Gerhard, G. T., & Duell, P. B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199910000-00006 · Cited by 167 · see citing works

Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F 2 -isoprostanes in human urine

Li, H., Lawson, J. A., Reilly, M. P., Adiyaman, M., Hwang, S., Rokach, J., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13381 · Cited by 161 · see citing works

Oxidative Stress and Platelet Activation in Homozygous Homocystinuria

Davı̀, G., Minno, G. D., Coppola, A., Andria, G., Cerbone, A. M., Madonna, P., Tufano, A., Falco, A., Marchesani, P., Ciabattoni, G., et al. (2001) · Circulation · doi:10.1161/hc3501.095287 · Cited by 133 · see citing works

Oxidative DNA Damage and Cardiovascular Disease

Lee, S. H. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00094-9 · Cited by 132 · see citing works

Inflammatory hypotheses: novel mechanisms of Alzheimer’s neurodegeneration and new therapeutic targets?

Praticò, D., & Trojanowski, J. Q. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00141-x · Cited by 116 · see citing works

Low-Density Lipoprotein Level Reduction by the 3-Hydroxy-3-Methylglutaryl Coenzyme-A Inhibitor Simvastatin Is Accompanied by a Related Reduction of F 2 -Isoprostane Formation in Hypercholesterolemic Subjects

Caterina, R. D., Cipollone, F., Filardo, F. P., Zimarino, M., Bernini, W., Lazzerini, G., Bucciarelli, T., Falco, A., Marchesani, P., Muraro, R., et al. (2002) · Circulation · doi:10.1161/01.cir.0000038500.43292.d7 · Cited by 113 · see citing works

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

Iuliano, L., Praticò, D., Greco, C., Mangieri, E., Scibilia, G., FitzGerald, G. A., & Violi, F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01040-8 · Cited by 112 · see citing works

Free-Radical-Induced Oxidation of Arachidonoyl Plasmalogen Phospholipids: Antioxidant Mechanism and Precursor Pathway for Bioactive Eicosanoids

Murphy, R. C. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000250t · Cited by 112 · see citing works

Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E

Tangirala, R. K., Praticò, D., FitzGerald, G. A., Chun, S. H., Tsukamoto, K., Maugeais, C., Usher, D. C., Puré, E., & Rader, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003324200 · Cited by 112 · see citing works

Oxidized LDL Contains Inflammatory PAF-Like Phospholipids

Marathe, G. K. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00100-1 · Cited by 110 · see citing works

Enhanced Lipid Peroxidation in Patients Positive for Antiphospholipid Antibodies

Iuliano, L., Praticò, D., Ferro, D., et al. (1997) · Blood · doi:10.1182/blood.v90.10.3931 · Cited by 110 · see citing works

Oxidative stress and diabetes mellitus

Kuyvenhoven, J. P., & Meinders, A. E. (1999) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(99)00009-6 · Cited by 103 · see citing works

Selective Interleukin-12 Synthesis Defect in 12/15-Lipoxygenase-deficient Macrophages Associated with Reduced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia

Zhao, L., Cuff, C. A., Moss, E., Wille, U., Cyrus, T., Klein, E. A., Praticò, D., Rader, D. J., Hunter, C. A., Puré, E., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205738200 · Cited by 102 · see citing works

Lipid peroxidation associated with successful thrombolysis

Ranjadayalan, K. (1990) · The Lancet · doi:10.1016/0140-6736(90)90866-4 · Cited by 96 · see citing works

Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer’s disease

Tuppo, E. E., FORMAN, L. J., Spur, B. W., Chan-Ting, R. E., Chopra, A., & Cavalieri, T. A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00450-6 · Cited by 84 · see citing works

Lipid Peroxidation and the Aging Process

Praticò, D. (2002) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2002.50.re5 · Cited by 83 · see citing works

Identification of Two Major F2 Isoprostanes, 8,12-Iso- and 5-epi-8,12-Iso-isoprostane F2α-VI, in Human Urine

Lawson, J. A., Li, H., Rokach, J., Adiyaman, M., Hwang, S., Khanapure, S. P., & FitzGerald, G. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29295 · Cited by 82 · see citing works

Ongoing Prothrombotic State in Patients With Antiphospholipid Antibodies: A Role for Increased Lipid Peroxidation

Praticò, D., Ferro, D., Iuliano, L., Rokach, J., Conti, F., Valesini, G., FitzGerald, G. A., & Violi, F. (1999) · Blood · doi:10.1182/blood.v93.10.3401.410k36_3401_3407 · Cited by 69 · see citing works

Increase of isoprostane 8-epi-PGF2 αafter restarting smoking

Chehne, F., Oguogho, A., Lupattelli, G., Budinsky, A. C., Palumbo, B., & Sinzinger, H. F. (2001) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0277 · Cited by 45 · see citing works

Specific Analysis in Plasma and Urine of 2,3-Dinor-5,6-dihydro-isoprostane F2α-III, a Metabolite of Isoprostane F2α-III and an Oxidation Product of γ-Linolenic Acid

Burke, A., Lawson, J. A., Meagher, E. A., Rokach, J., & FitzGerald, G. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2499 · Cited by 41 · see citing works

Lipid Peroxidation in Mouse Models of Atherosclerosis

Praticò, D. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00099-8 · Cited by 39 · see citing works

Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F2α-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E

Praticò, D., Tangirala, R. K., Hörkkö, S., et al. (2001) · Blood · doi:10.1182/blood.v97.2.459 · Cited by 35 · see citing works

Oxidative Stress and Diabetes Mellitus

Sen, S., Chakraborty, R., & De, B. (2016) · Springer eBooks · doi:10.1007/978-981-10-1542-7_7 · Cited by 11 · see citing works

Untitled work

(2000) · doi:10.1002/1531-8249(200011)48:5

Reactive oxygen species in cardiovascular disease

Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769 · see citing works

Keap1 Recruits Neh2 through Binding to ETGE and DLG Motifs: Characterization of the Two-Site Molecular Recognition Model

Tong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2887-2900.2006 · Cited by 759 · see citing works

A Meta-analysis of oxidative stress markers in depression

Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485 · see citing works

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder

Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205 · see citing works

Peripheral Markers of Depression

Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197 · see citing works

Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression

Dimopoulos, N., Piperi, C., Psarra, V., Lea, R. W., & Kalofoutis, A. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.019 · Cited by 118 · see citing works

Enzyme Immunoassay of Isoprostanes

Callewaert, D. M., & Sloan, C. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_26 · Cited by 10 · see citing works

ISOPROSTANES—RROSTAGLANDIN-LIKE COMPOUNDS FORMED IN VIVO INDEPENDENTLY OF CYCLOOXYGENASE

Awad, J. A., Roberts, L. J., Burk, R. F., & Morrow, J. D. (1996) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70255-7 · Cited by 70 · see citing works

THE ISOPROSTANES: THEIR QUANTIFICATION AS AN INDEX OF OXIDANT STRESS STATUS IN VIVO†

Morrow, J. D. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100102340 · Cited by 187 · see citing works

Isoprostanes: markers and mediators of oxidative stress

Montuschi, P., Barnes, P. J., & Roberts, L. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-2330rev · Cited by 747 · see citing works

The Isoprostanes: Unique Products of Arachidonic Acid Oxidation-A Review

Fam, S. S., & Morrow, J. D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457115 · Cited by 263 · see citing works